Skip to main content

Table 2 Information provided to patients during phase 1 and phase 3

From: Group-based patient education delivered by nurses to meet a clinical standard for glaucoma information provision: the G-TRAIN feasibility study

Category from the VIM tool

Phase 1

Phase 3

112 patients

16 patients

Management—investigations, e.g. fields test

88% (99)

100% (16)

Self-management—importance of taking eyedrops

83% (93)

100% (16)

Management—regular monitoring

63% (70)

81% (13)

Management—appointment issues

63% (70)

94% (15)

Treatment—options for eyedrops

60% (67)

100% (16)

Risk—family

55% (62)

100% (16)

Diagnosis

54% (60)

100% (16)

Treatment—side effects

43% (48)

100% (16)

Prognosis—loss of sight

24% (27)

100% (16)

Driving

16% (18)

94% (15)

Support—help with eyedrops

13% (15)

100% (16)

Prognosis—symptomless

11% (12)

100% (16)

Prognosis—sight can’t be recovered

10% (11)

100% (16)

Support—support groups

10% (11)

94% (15)

Prognosis—when treated most don’t go blind

3% (3)

100% (16)

Registration of loss of sight

2% (2)

6% (1)

  1. NB. Phase 3, registration of loss of sight, one patient was given information in response to an individual question which was not widely discussed with the whole group
  2. VIM Provision of Vision Information Measurement tool